Correlation Between Reviva Pharmaceuticals and Scorpius Holdings

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Scorpius Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Scorpius Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Scorpius Holdings, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Scorpius Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Scorpius Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Scorpius Holdings.

Diversification Opportunities for Reviva Pharmaceuticals and Scorpius Holdings

-0.57

Correlation Coefficient

Reviva Pharmaceuticals  Scorpius Holdings

Excellent diversification

The 3 months correlation between Reviva and Scorpius is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Scorpius Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scorpius Holdings and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Scorpius Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scorpius Holdings has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Scorpius Holdings go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Scorpius Holdings

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 2.09 times more return on investment than Scorpius Holdings. However, Reviva Pharmaceuticals is 2.09 times more volatile than Scorpius Holdings. It trades about 0.13 of its potential returns per unit of risk. Scorpius Holdings is currently generating about -0.07 per unit of risk. If you would invest  13.00  in Reviva Pharmaceuticals Holdings on October 23, 2024 and sell it today you would earn a total of  4.00  from holding Reviva Pharmaceuticals Holdings or generate 30.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Scorpius Holdings

Reviva Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Scorpius Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scorpius Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Reviva Pharmaceuticals and Scorpius Holdings

The main advantage of trading using opposite Reviva Pharmaceuticals and Scorpius Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Scorpius Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scorpius Holdings will offset losses from the drop in Scorpius Holdings' long position.

The idea behind Reviva Pharmaceuticals Holdings and Scorpius Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.